Sophie Baratte
Chief Executive Officer bei CELLNOVO
Profil
Sophie Baratte is currently the Chief Executive Officer & Director at Cellnovo Group SA since 2016.
She previously held the position of Chief Executive Officer & Director at Cellnovo Ltd.
Sophie also served as an Independent Director at Stentys SA from 2017 to 2021.
She holds an MBA from École des Hautes Études Commerciales de Paris and a doctorate from the University of Compiègne.
Aktive Positionen von Sophie Baratte
| Unternehmen | Position | Beginn |
|---|---|---|
| CELLNOVO | Chief Executive Officer | 30.01.2016 |
Ehemalige bekannte Positionen von Sophie Baratte
| Unternehmen | Position | Ende |
|---|---|---|
| STENTYS | Director/Board Member | 01.03.2021 |
Cellnovo Ltd.
 Cellnovo Ltd. Medical SpecialtiesHealth Technology Cellnovo Ltd. manufactures diabetes management devices. The private company is based in Bridgend, UK. The British company was founded by Julian Shapley. The CEO is Sophie Baratte. | Chief Executive Officer | - |
Ausbildung von Sophie Baratte
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
| University of Compiègne | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Stentys SA
 Stentys SA Medical SpecialtiesHealth Technology Stentys SA engages in the design, development, and marketing of self-expanding stents used in treating cardiovascular diseases. It provides solutions for the treatment of acute myocardial infarction and other complex coronary diseases. Its products include Xposition S, Devoir, AmazoniaSir, stemiCath, Yangtzenano and YangtzeNC. The company was founded by Gonzague Issenmann and Jacques Seguin on July 6, 2006 and is headquartered in Neuilly-sur-Seine, France. | Health Technology |
Cellnovo Ltd.
Cellnovo Ltd. Medical SpecialtiesHealth Technology Cellnovo Ltd. manufactures diabetes management devices. The private company is based in Bridgend, UK. The British company was founded by Julian Shapley. The CEO is Sophie Baratte. | Health Technology |
Cellnovo Group SA
 Cellnovo Group SA Medical SpecialtiesHealth Technology Cellnovo Group SA was a medical technology company, which specialized in diabetes. The company developed and marketed the first mobile, connected, all-in-one diabetes management system that helps make life easier for patients. It products portfolio included system, switch, pump therapy, and patient stories. The company was founded by Julian Shapley on December 15, 2014 and was headquartered in Paris, France. | Health Technology |
